- Home
- BCDA vs MSN Comparison
BCDA vs MSN Comparison
Compare BCDA & MSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- MSN
- Stock Information
- Founded
- BCDA N/A
- MSN 1948
- Country
- BCDA United States
- MSN United States
- Employees
- BCDA N/A
- MSN N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- MSN Consumer Electronics/Appliances
- Sector
- BCDA Health Care
- MSN Consumer Staples
- Exchange
- BCDA Nasdaq
- MSN Nasdaq
- Market Cap
- BCDA 11.3M
- MSN 9.3M
- IPO Year
- BCDA N/A
- MSN 1994
- Fundamental
- Price
- BCDA $2.06
- MSN $0.42
- Analyst Decision
- BCDA Strong Buy
- MSN
- Analyst Count
- BCDA 1
- MSN 0
- Target Price
- BCDA $25.00
- MSN N/A
- AVG Volume (30 Days)
- BCDA 62.9K
- MSN 348.3K
- Earning Date
- BCDA 08-11-2025
- MSN 08-14-2025
- Dividend Yield
- BCDA N/A
- MSN N/A
- EPS Growth
- BCDA N/A
- MSN N/A
- EPS
- BCDA N/A
- MSN N/A
- Revenue
- BCDA N/A
- MSN $10,262,000.00
- Revenue This Year
- BCDA N/A
- MSN N/A
- Revenue Next Year
- BCDA N/A
- MSN N/A
- P/E Ratio
- BCDA N/A
- MSN N/A
- Revenue Growth
- BCDA N/A
- MSN 8.49
- 52 Week Low
- BCDA $1.63
- MSN $0.28
- 52 Week High
- BCDA $3.26
- MSN $0.59
- Technical
- Relative Strength Index (RSI)
- BCDA 56.99
- MSN 49.83
- Support Level
- BCDA $1.90
- MSN $0.38
- Resistance Level
- BCDA $1.99
- MSN $0.44
- Average True Range (ATR)
- BCDA 0.08
- MSN 0.04
- MACD
- BCDA 0.03
- MSN -0.00
- Stochastic Oscillator
- BCDA 90.00
- MSN 53.21
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About MSN Emerson Radio Corporation
Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.